References
- Parkin D, Fernàndez LM. Use of statistics to assess the global burden of breast cancer. Breast J 2006; 12: 70–80
- Kimman ML, Voggd AC, Dirksen CD, Falger P, Hupperets P, Keymeulen K, et al. Follow-up after curative treatment for breast cancer: Why do we still adhere to frequent outpatient clinic visits?. Eur J Cancer 2007; 43: 647–53
- Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: A randomized trial. Breast Cancer Res Treat 2005; 93: 255–60
- Hensley ML, Dowell J, Herndon JE, Winer E, Stark N, Weeks JC, et al. Economic outcomes of breast cancer survivorship: CALGB study 79804. Breast Cancer Res Treat 2005; 91: 153–61
- Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol 2004; 5: 568–74
- Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, et al. Comparison of breast cancer patient satisfaction with follow-up in a primary care versus specialist care: Result from a randomised controlled trial. Br J Gen Pract 1999; 49: 705–10
- Brown L, Payne S, Royle G. Patient initiated follow-up of breast cancer. Psycho-oncology 2002; 11: 346–55
- Rojas MP, Telaro E, Russo A, Moschetti I, Coe L, Fossati R, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005.
- McArdle JM, George WD, McArdle CS, Smith DC, Moodie AR, Hughson AV, et al. Psychosocial support for patients undergoing breast cancer surgery: A randomised study. Br Med J 1996; 30: 813–6
- Koinberg I, Fridlund B, Engholm G-B, Holmberg L. Nurse-led follow-up on demand or by a physician after breast cancer surgery: A randomised study. Eur J Oncol Nurs 2004; 8: 109–17
- Arving C, Sjöden PO, Bergh J, Hellbom M, Johansson B, Glimelius B, et al. Individual psychosocial support for breast cancer patients: A randomized study of nurse versus psychologist interventions and standard care. Cancer Nursing 2007; 30: E10–E19
- Kimman ML, Voggd AC, Dirksen CD, Falger P, Hupperets P, Keymeulen K, et al. Improving the quality and efficiency of follow-up after curative treatment for breast cancer-rationale and study design of the MaCare trial. Eur J Cancer 2007; 7: 1
- Drummond MF, O'Brien B, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford Medical Publication, Oxford 1997
- Sobin Wittekind CH. TNM classification of malignant tumours5th ed. Wiley-Liss, New York 2002
- Gold MR, Siegel JE., Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. Oxford University Press, Oxford 1996
- Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479–500
- Efron B, Tibshirani RJ. An introduction to the bootstrap. Chapman & Hall/CRC; 1993.
- Brennan A, Akehurst R. Modelling in health economic evaluation – What is its Place? What is its Value?. Pharmacoeconomics 2000; 17: 445–59
- Canty A, Ripley B. Boot: Bootstrap R (S-Plus) Functions (Canty). 2006 R package version 1.2-26. < [email protected]>, < [email protected]>
- R Development Core Team 2007. R: A language and environment for statistical computing. Foundation for Statistical Computing, ViennaAustria. ISBN 3-900051-07-0, URL http://www.R-project.org.
- Lidgren M, Wilking N, Jönsson B, Rehnberg C. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 2007; 23: 223–31
- Cancer Incidence in Sweden 2005. The National Board of Health and Welfare, Stockholm. www.socialstyrelsen.se.
- Helgesen F, Andersson S-O, Gustafsson O, Varenhorst E, Gobén B, Carnock S, et al. Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: A randomised study. Scand J Urol Nephrol 2000; 34: 55–61
- Radice D, Redaelli A. Breast cancer management: Quality-of-life and cost consideration. Pharmaeconomics 2003; 21: 383–96
- Sikora K, Bosanguet N. Cancer care in the United Kingdom: New solutions are needed. Br Med J 2003; 327: 1044–6